Search
Establishment Labs Holdings Inc
ESTAAdd to Watchlist
92.540USD
-0.940-1.01%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.72BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Establishment Labs Holdings Inc is 8.44, ranking 36 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 75.00, with a high of 85.00 and a low of 62.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
96.125
Target Price
+4.56%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Establishment Labs Holdings Inc
ESTA
9
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Establishment Labs Holdings Inc's expected revenue for the next quarter?
Establishment Labs Holdings Inc's expected revenue is 65.77M.
What is Establishment Labs Holdings Inc's price target?
Analysts forecast that Establishment Labs Holdings Inc's price target is USD 75.00, with the highest forecast at USD 85.00 and the lowest forecast at USD 62.00.
How have Establishment Labs Holdings IncESTA's recent earnings per share performed?
The market expectation was USD -0.45, while Establishment Labs Holdings IncESTA's earnings per share (EPS) for the previous quarter was USD -0.09. EPS for the next quarter is expected at USD -0.34.
What is the analyst rating for Establishment Labs Holdings Inc?
Based on the ratings of Establishment Labs Holdings Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.